A 2-year-old spayed female Labrador Retriever presents ac...

☠️ Alright, this is a critical situation, and time is of the essence. A collapsed patient with severe hypoglycemia after xylitol ingestion is a true emergency. The elevated ALT at 30 minutes post-ingestion indicates a significant, rapid hepatic insult, likely from a high dose of xylitol (>0.5 g/kg).

Here's the immediate stabilization protocol and long-term monitoring plan:

Immediate Stabilization Protocol (First 1-2 Hours)

Establish IV Access & Address Hypoglycemia:

* Immediately place a large-bore intravenous catheter.
* Administer a dextrose bolus: 0.5-1 mL/kg of 50% dextrose, diluted 1:1 with crystalloid fluids (e.g., 25% dextrose solution). Administer slowly over 3-5 minutes.
* Initiate a dextrose constant rate infusion (CRI): Immediately follow the bolus with a 2.5-5% dextrose CRI to maintain euglycemia. The exact rate will depend on ongoing glucose monitoring.
* Monitor blood glucose every 15-30 minutes initially until stable, then hourly.

Decontamination (Cautious Approach):

* Given the patient's collapsed state and severe hypoglycemia, emesis is absolutely contraindicated due to the high risk of aspiration.
* Activated charcoal: Xylitol is poorly adsorbed by activated charcoal, but given the unknown quantity and potential for other ingredients in the gum, it's often considered. However, in a collapsed patient, administration carries a significant aspiration risk. If the patient can be intubated and protected, a single dose of activated charcoal (1-2 g/kg PO) could be considered, but managing hypoglycemia and stabilization takes precedence.

Supportive Care & Hepatoprotection:

* Start IV fluids (e.g., Lactated Ringer's Solution or 0.9% NaCl) at a maintenance rate to support hydration and perfusion, especially to the liver.
* Given the acute liver injury (ALT 450 U/L), initiate hepatoprotectants without delay:
* N-acetylcysteine (NAC): Administer a loading dose of 140 mg/kg IV or PO, followed by 70 mg/kg IV or PO every 4-6 hours for 7 doses. This is crucial for glutathione replenishment and liver support.
* Consider S-adenosylmethionine (SAMe) at 18-20 mg/kg PO daily, if the patient can tolerate oral medications after stabilization.

Long-Term Monitoring Plan (Beyond Initial Stabilization)

Continuous Blood Glucose Monitoring:

* Continue hourly blood glucose checks for the first 12-24 hours.
* Gradually decrease monitoring frequency (e.g., q2-4h) as glucose stabilizes and the dextrose CRI is weaned. The duration of insulin release can be prolonged, so vigilance is key for at least 24-48 hours.

Comprehensive Liver Monitoring:

* Baseline bloodwork: (already done, but recheck to trend).
* Liver enzymes: Recheck ALT, ALP, GGT, and bilirubin at 12, 24, 48, and 72 hours post-ingestion. Significant increases indicate ongoing liver damage.
* Coagulation profile: Monitor PT, PTT, and platelet count at 24, 48, and 72 hours. Liver failure can impair the production of clotting factors.
* Albumin, Glucose, BUN: These are indicators of liver synthetic function and should be monitored.

Electrolyte and Renal Function:

* Monitor electrolytes (especially potassium, which can be affected by dextrose infusions) and renal values (BUN, creatinine) every 12-24 hours.

Supportive Care Continuation:

* IV fluids: Continue IV fluids to ensure adequate hydration and renal perfusion.
* Hepatoprotectants: Continue NAC (as per protocol) and SAMe for several days to weeks, depending on the severity and resolution of liver enzyme elevations.
* Nutritional Support: Once stable, provide small, frequent meals of a highly digestible, low-fat diet.

Prognosis

The immediate prognosis for hypoglycemia is good with aggressive and timely dextrose supplementation. However, the pre-existing elevated ALT indicates acute hepatic injury, which significantly worsens the overall prognosis. Xylitol-induced hepatotoxicity can be severe and progressive, leading to acute liver failure, coagulopathy, and death. Intensive care with close monitoring and aggressive liver support is essential. If liver values continue to rise or coagulation abnormalities develop, the prognosis becomes guarded to poor.

This patient requires immediate and aggressive inpatient care in an emergency or referral setting.